- Conditions
- Mitral Valve Regurgitation, Left Atrium Dilatation and Hypertrophy, Mitochondrial Dysfunction in the Heart, Cardiomyocyte Apoptosis, Cardiac Inflammation
- Interventions
- Lovaza group
- Drug
- Lead sponsor
- East Carolina University
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 1
- States / cities
- Greenville, North Carolina
Source: ClinicalTrials.gov public record
Updated Sep 9, 2013 · Synced May 22, 2026, 5:47 AM EDT